🇺🇸 FDA
Pipeline program

Trivalent influenza vaccine (TIVc)

V58P16

Phase 2 mab completed

Quick answer

Trivalent influenza vaccine (TIVc) for Influenza is a Phase 2 program (mab) at Seqirus (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Seqirus (Australia) Pty Ltd
Indication
Influenza
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials